Titan Pharmaceuticals
TTNP
$6.85
Share price
-1.72%
Change (1 day)
778.21%
Change (1 year)
Categories
Earnings for Titan Pharmaceuticals (TTNP)
Earnings in 2023 (TTM): -$5.57 M
According to Titan Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are -$5.57 M. In 2022 the company made an earning of -$10.21 M a decrease over its 2021 earnings that were of -$8.78 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Titan Pharmaceuticals from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$5.57 M | -45.43% |
| 2022 | -$10.21 M | 16.29% |
| 2021 | -$8.78 M | -907.36% |
| 2020 | $1.08 M | -106.6% |
| 2019 | -$16.46 M | 82.4% |
| 2018 | -$9.03 M | -36.93% |
| 2017 | -$14.31 M | -378.62% |
| 2016 | $5.13 M | -145.53% |
| 2015 | -$11.28 M | 369.37% |
| 2014 | -$2.41 M | -125.9% |
| 2013 | $9.27 M | -177.74% |
| 2012 | -$11.94 M | 13.59% |
| 2011 | -$10.51 M | 74.37% |
| 2010 | -$6.03 M | 3.61% |
| 2009 | -$5.82 M | |
| 2007 | -$18.44 M | 12.08% |
| 2006 | -$16.45 M | -28.65% |
| 2005 | -$23.06 M | -10.03% |
| 2004 | -$25.63 M | -6.08% |
| 2003 | -$27.28 M | -14.76% |
| 2002 | -$32.01 M | 32.52% |
| 2001 | -$24.15 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $16.97 B | -304,858.48% | 🇺🇸 USA |
 Novartis NVS | $9.82 B | -176,558.97% | 🇨🇭 Switzerland |
 Vanda Pharmaceuticals VNDA | -$13.96 M | 150.53% | 🇺🇸 USA |
 Repligen
RGEN | $66.08 M | -1,286.62% | 🇺🇸 USA |
 MediciNova MNOV | -$8.57 M | 53.86% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | -$0.15 B | 2,450.58% | 🇺🇸 USA |